Dabigatran-based dual antithrombotic therapy for patients with atrial fibrillation and ST-elevation myocardial infarction undergoing percutaneous coronary intervention

MeSH terms

• Anticoagulants / adverse effects
• Atrial Fibrillation* / complications
• Atrial Fibrillation* / drug therapy
• Dabigatran / adverse effects
• Drug Therapy, Combination
• Fibrinolytic Agents / adverse effects
• Humans
• Percutaneous Coronary Intervention* / adverse effects
• Platelet Aggregation Inhibitors / adverse effects
• ST Elevation Myocardial Infarction* / drug therapy
• Treatment Outcome